Barriers and facilitators to HIV testing
Published by: The Public Health Agency of Canada
Issue: Volume 41-12: Good news on HIV
Date published: December 3, 2015
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
Volume 41-12, December 3, 2015: Good news on HIV
Review
An overview of recent evidence on barriers and facilitators to HIV testing
Traversy GP1, Austin T1, Ha S1, Timmerman K1*, Gale-Rowe M1
Affiliation
1 Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON
Correspondence
DOI
https://doi.org/10.14745/ccdr.v41i12a02
Abstract
Background: To address the issue of undiagnosed HIV infections, the Public Health Agency of Canada released the Human Immunodeficiency Virus—HIV Screening and Testing Guide in 2012, which identified several barriers and facilitators for HIV testing.
Objective: The objective of this overview is to summarize the most recent evidence regarding barriers and facilitators to HIV testing, to expand upon the research conducted for the HIV Screening and Testing Guide.
Methods: A review of the literature published between 2010 and 2014 was conducted using Scopus, PubMed (MEDLINE), and the Cochrane Library; websites of groups such as the Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, Australian Department of Health, and New Zealand Ministry of Health were searched for recent reports. Studies were categorized based on the barrier or facilitator identified, and the results were summarized.
Results: In addition to the known barriers of lack of perceived risk, lack of comfort or knowledge, provider time constraints, and fear of the diagnosis, stigma and discrimination, new studies have identified additional barriers including: fear regarding disclosure or lack of confidentiality, lack of access, lack of compensation of providers, and lack of human resources to carry out testing. In addition to the known facilitators of increased awareness and normalization of HIV screening and testing, opt-out testing was identified as a facilitator in recent studies.
Conclusion: Since 2010, research has advanced our knowledge of barriers and facilitators and can be applied to help decrease the number of undiagnosed HIV infections.
Introduction
Human immunodeficiency virus (HIV) infection is now largely considered a manageable condition due to advances in treatment. Without appropriate interventions, however, HIV can progress to acquired immune deficiency syndrome (AIDS), which can lead to illness and death. Reducing the spread of HIV in Canada requires concerted efforts at widespread screening and testing to identify individuals who may miss opportunities to obtain treatment, and thus unknowingly be transmitting the virus to others. Providing early HIV diagnosis is important in preserving quality of life for those who are infected, and reducing the number of undiagnosed cases of HIV will help to prevent transmission of the virusFootnote 1.
In Canada, approximately 75,500 individuals were living with HIV at the end of 2014 and an estimated 21% of those were unaware of their infectionFootnote 2. To complement existing initiatives to reduce the number of undiagnosed HIV cases in Canada, the Public Health Agency of Canada (the Agency) released the Human Immunodeficiency Virus—HIV Screening and Testing Guide (the Guide) in 2012 to support health care providers with normalizing HIV testingFootnote 1. Within the Guide, several barriers and facilitators to HIV screening and testing were identified, specifically: lack of perceived risk for HIV infection among patients and providers; comfort and knowledge with respect to HIV testing among patients and providers; providers’ time constraints; cumbersome consent procedures; and managing fears of stigma or discrimination associated with testing and risk behaviours in generalFootnote 1.
The studies used to inform the Guide were published prior to 2010Footnote 1. As the implementation and normalization of routine HIV screening and testing remain an important issue for public health in Canada, a broad overview of more recent studies on the barriers and facilitators of HIV testing was warranted. We chose to do an overview of the literature because the inconsistent definition of barriers and facilitators across studies as well as the overlap between barriers and facilitators limited the ability to perform a systematic review.
The objective of this overview was to summarize the most recent evidence regarding barriers and facilitators of HIV screening and testing in Canada, and similar developed countries in order to help identify gaps in knowledge, and potentially inform future revisions to the Guide.
Methods
A literature review was conducted using databases such as Scopus, PubMed (MEDLINE), and the Cochrane Library. Search terms included “HIV” or “human immunodeficiency virus” and “screening” or “testing” and “barriers” or “facilitators” or “predictors.” Other literature sources searched for relevant reports included the websites of the Centers for Disease Control and Prevention (CDC), the European Centre for Disease Prevention and Control (ECDC), the Australian Department of Health, and the New Zealand Ministry of Health. Studies and reports from Canada, the United States, Europe, Australia, and New Zealand, published between 2010 and 2014, were included in the literature review; editorials, commentaries and letters to the editor were excluded. The key barriers and facilitators identified in each of the studies were reviewed and categorized, and evidence tables were developed to summarize and organize the key findings. The organization of study results into barrier and facilitator categories was confirmed by two of the authors of this article—S. Ha and T. Austin. Barriers and facilitators are described in Table 1.
Barriers | Definition |
---|---|
Lack of perceived risk of HIV infection |
For patients: the patient does not believe he/she has a risk of acquiring HIV, or believes that his/her behaviours prevent risk. For providers: the provider does not believe his/her patients have a risk of acquiring HIV, or assumes they are at low risk, and may also believe that HIV is not an issue for his/her patient population or region of practice. |
Comfort discussing and lack of knowledge of HIV |
For patients: the patient does not feel comfortable discussing HIV or other sexual issues with the provider, and may have a general lack of knowledge about HIV, or how and where to get tested. For providers: the provider feels discomfort or anxiety in asking sexual questions to the patient, or in eliciting patient fears regarding HIV. He/she may lack knowledge of consent procedures, how to manage positive results and reporting procedures for their jurisdiction, and may feel that a lack of specific training prevents them from testing for HIV. |
Health care provider time constraints |
Health care providers have a lack of time for HIV testing and associated counselling, or have competing priorities during a visit that prevent them from testing for HIV. |
Fear, stigma and discrimination |
The patient fears a positive result, social repercussions for seeking testing or for testing positive (discrimination, rejection), being unable to cope with results, or that he/she will see someone he/she knows at the clinic. |
Access to testing |
A lack of ability to access testing in general (due to remote/rural location, lack of insurance [U.S. studies], testing location hours of operation, language barriers), or an inability to access a variety of testing services that are typically available (e.g., lack of anonymous testing in rural locations vs. metropolitan locations) acts as a barrier to testing. |
Financial and human resource constraints |
Cases where providers may not perform HIV testing due to a lack of compensation, or there is an inability to run HIV testing initiatives due to lack of staff. |
Normalizing HIV testing |
Reducing the negative stigma surrounding HIV by making it a routine test (similar to checking cholesterol, for instance). Offering testing as part of regular care. |
Opt-out testing |
HIV testing is offered and administered unless the patient specifically refuses. |
Increasing knowledge and awareness |
Using patient-centred educational material to make patients more knowledgeable, more likely to see HIV testing as a positive thing, and improve interest in testing. |
Results
Overall 34 studies and reports on barriers and facilitators to HIV testing were identified. The majority of these were American, while a smaller number were from European countries and Australia. One report and one study were from Canada; no literature was found from New Zealand.
Barriers
Lack of perceived risk of HIV infection
An important barrier to HIV testing is the perceived lack of risk that stems from the inability to accurately assess levels of risk, either for one’s self (on the part of patients or clients) or for patients (on the part of health care providers), which has the potential to act as a barrier. In a systematic review of European studies by Deblonde et al., low risk perception was identified as a barrier in four (out of 24) of the studies analyzedFootnote 3. In a survey of 629 Europeans recently diagnosed with HIV, 73% of respondents indicated that low risk perception was a reason for not having previously been testedFootnote 4. A survey of 519 HIV‑negative men in Australia found that 41.2% of respondents cited believing they had not engaged in risky behaviour as a reason for delaying or avoiding testingFootnote 5. Similarly, several American interview‑based studies have looked at barriers to initial testing in patients with HIV/AIDS, or factors that contributed to late diagnosis of HIV in individuals who developed AIDS within 12 months of HIV diagnosisFootnote 6Footnote 7Footnote 8.
Low risk perception is a recurring theme among these studiesFootnote 6Footnote 7Footnote 8. One of these studies, from San Francisco, found that low risk perception was mentioned by 14 out of 41 interviewees, and another from New York found that 89 of 139 interviewees cited low risk perceptionFootnote 7Footnote 8. Health care providers from North Carolina interviewed by White et al. also identified low risk perception as a patient barrier towards routine testingFootnote 9. In addition, interviews with primary care providers, infectious disease specialists and internal medicine residents have suggested that patients’ perceived lack of risk poses a challenge for testingFootnote 10Footnote 11. Therefore, patients who perceive themselves as low risk for HIV infection are less likely to seek HIV testing.
In contrast, inappropriate assessment of risk by health care providers themselves may also act as a barrier. Among health care providers, results from surveys and interviews have found inaccurate or low risk perception to be a common barrier to HIV testing. In a survey of 221 health care providers in Washington, 57% agreed that perceiving the patient as low risk is a barrier to testingFootnote 12. Open‑ended interviews with 24 health care providers in Mississippi and Rhode Island also identified incorrect assumptions of patients’ risks as a barrierFootnote 13. In a survey of HIV testing coordinators, program directors, nurse managers and laboratory directors from hospitals, community-based organizations and clinics/health centres in Washington, DC, and Houston, Texas, a frequently selected barrier was that HIV was not an issue for the patient population (68.6% in Washington, 20.9% in Houston)Footnote 14. Similarly, in a survey of 515 clinical educators from the Society of General Internal Medicine in the U.S., reasons behind whether or not trainees were encouraged to perform routine HIV testing were investigated. The most common reason for not encouraging trainees to perform routine HIV testing was a perception of low local prevalenceFootnote 15.
Lack of knowledge and discomfort
Lack of knowledge is an important barrier for patients and it influences other barriers. A U.S. survey of 443 adults in nine academic internal medicine clinics found that significant predictors of self‑reported HIV testing were a patient’s knowledge about HIV (odds ratio [OR]=1.3), as well as patient request for testing (OR=103.3)Footnote 16. As a result, the authors suggest that “simple waiting room prompts (to ask for HIV testing) and public education campaigns may represent the most efficient interventions to increase HIV testing rates”Footnote 16. Lack of knowledge may also be a factor in terms of where to go for testing; this was described as a barrier in the systematic review by Deblonde et al.Footnote 3. Patient discomfort or refusal of testing was also cited as a barrier in one American studyFootnote 14.
Several barriers to routine HIV testing related to health care providers’ knowledge and comfort level have been identified. In studies from the U.S., lack of familiarity with local regulations regarding HIV testing procedures and disagreements with national recommendations were considered barriers to HIV testingFootnote 15Footnote 17Footnote 18. A barrier resulting from a systematic review was provider anxiety about offering HIV testing in a primary care settingFootnote 3. Similarly, interviews with health care providers in Mississippi, Rhode Island and Massachusetts identified discomfort in initiating conversations about HIV testing as a barrierFootnote 13Footnote 19. Other studies in the United States and Europe suggest that fears about how to deal with positive results, as well as feelings of inexperience or lack of training with respect to procedures and regulations, may act as a barrier for health care providersFootnote 11Footnote 13Footnote 17Footnote 18Footnote 20Footnote 21.
Health care provider time constraints
Time constraints and competing priorities during patient visits are commonly experienced by health care providers. Time constraints can arise due to lengthy consent procedures (depending on local regulations) as well as lengthy pre- and post-test counselling proceduresFootnote 9Footnote 12Footnote 15Footnote 17Footnote 18Footnote 20Footnote 22Footnote 24. Health care providers may perceive time constraints as a barrier due to the lack of familiarity of local regulations (e.g., if they are unaware that testing requires only verbal consent, they may perceive the procedures required to obtain consent as being more time consuming than they actually are).
Fear, stigma and discrimination
When patients are fearful of positive results, they may be less likely to request an HIV testFootnote 3Footnote 5Footnote 25. Thus, fear of the test itself or of potential positive results may act as a barrier, in addition to fears of being discriminated against or stigmatized. In recent literature, fear of stigma or discrimination from the community have emerged as barriers to HIV testing and may deter a patient from seeking HIV testing in the first placeFootnote 25Footnote 26Footnote 27. In particular, this may be evident in small communities where the patient may be likely to encounter individuals he/she knows during the testing processFootnote 23. Patient fear of social repercussions due to a positive test is a very commonly mentioned barrier, both by patients and health care providersFootnote 4Footnote 7Footnote 9Footnote 11Footnote 22Footnote 26Footnote 28Footnote 29.
Patient fear regarding the possibility of disclosure or a lack of confidentiality is another barrier to HIV testingFootnote 3Footnote 4Footnote 27. Youth may have particular reason to fear disclosure due to staff being unaware of testing confidentiality practices. In a study examining barriers to youth HIV testing in New York, of 131 HIV testing site representatives that were interviewed using a “secret shopper” approach, 14% either gave incorrect information, or did not know, when asked whether parents could find out the youth’s test resultFootnote 30. Fears with respect to anonymity likely also reflect fears regarding the stigma associated with testing and the potential discrimination from family or community members. Health care providers interviewed in one study suggested that assurances of confidentiality for the patients were of great importance as a facilitatorFootnote 13. Patient fears related to stigma, consequences of positive results and confidentiality could also potentially stem from a lack of knowledge (e.g., a patient may not realize that they can live a long healthy life with current HIV treatments, in the case of a positive test), highlighting the overlap that can exist among barriers.
Access to testing
People living in rural or remote areas may not be able to access a variety of HIV testing services as easily as people living in denser metropolitan areas. Providers in Mississippi, for example, suggested that the need to travel long distances for testing services was a barrier for patients in their jurisdictionFootnote 11. In a separate U.S. study of individuals who received late diagnoses of HIV, living in a rural area was more commonly associated with late diagnoses than living in an urban areaFootnote 31. Similarly, an Australian study found that having a practice in a metropolitan area was associated with more HIV testing than having a practice in a non-metropolitan area (OR=1.40)Footnote 32.
In a Canadian review of barriers faced by women with respect to HIV testing, the author stressed that anonymous testing may not be universally availableFootnote 26. Among adolescents receiving rapid HIV testing in an emergency department (n=114), 80% of those surveyed stated they would be more likely to get a test if a rapid version was availableFootnote 33. In the study by Hyden et al., in which 131 HIV testing site representatives in New York were interviewed, only 12% of the sites provided testing outside the hours of 08:30 to 17:00, Monday to FridayFootnote 30. Similarly, 23% of the sites exclusively offered testing on weekdays between 09:00 and 15:00. Thus, the operating hours of testing sites could represent a significant barrier to youth who are in school, as well as those who are unable to take time off work during the week. In a survey of Australian HIV-negative men, 15.2% of participants cited difficulty getting an appointment as a reason for delaying testingFootnote 5. Health care providers have also identified that language barriers may also act as a barrier to accessing HIV testingFootnote 12Footnote 18Footnote 34.
Financial and human resource constraints
Health care providers frequently mentioned lack of resources or compensation as personal and institutional barriers. Having financial and physical resources, as well as being able to employ enough staff to run routine HIV testing initiatives within hospitals and community clinics, emerged as a barrier within American and European studiesFootnote 3Footnote 13Footnote 14Footnote 18Footnote 20. Health care providers have also cited a lack of compensation for the extra time spent on HIV testing and its related procedures as a barrierFootnote 9Footnote 11Footnote 22Footnote 23. Due to the lack of recent Canadian studies in this area, it is not entirely clear whether these issues would emerge as barriers in Canada.
A summary of recent studies on barriers to HIV testing is presented in Appendix 1.
Facilitators
Normalizing HIV testing
The Agency, the CDC and the ECDC recommend normalizing HIV testing by including it as part of routine careFootnote 1Footnote 22Footnote 35. Including HIV testing as a component of periodic routine medical care is a multi-faceted approach in the sense that normalized testing not only reduces the stigma associated with HIV, but also encourages more patients to be receptive to the idea of testing, and to be testedFootnote 1Footnote 10Footnote 16Footnote 29Footnote 33. Several sources have highlighted that patients are more likely to be tested for HIV if they are offered a test as opposed to requesting the test themselvesFootnote 16Footnote 29Footnote 33. According to Haines et al., 67% of surveyed adolescents stated that they would be more likely to participate in testing if it were offered, as opposed to having to request itFootnote 33.
Normalized testing has been linked to reduced stigma among patients who are tested for HIV. In a survey of Scottish men who have sex with men (MSM), individuals who had been tested in the past year had less fear of positive results, and a greater testing norm than those who had been tested more than one year ago, or had never been testedFootnote 36. Other studies suggest that “HIV should be no different than screening for glucose levels, cholesterol levels, or blood pressure”Footnote 17.
Opt-out testing
With opt-out testing, HIV testing is offered and administered, unless explicitly refused by the patient. Opt‑out testing has been identified as a potential facilitator for HIV testing as it eliminates the requirement for lengthy consent procedures, removing this barrier for health care providers and patients. In this sense it addresses the issue of a lack of time, as well as concerns regarding any lack of reimbursement for extra time spent. Although opt-out testing could be effective in increasing testing ratesFootnote 3 it is important that patients have the capacity to consent and understand the implications of an HIV test. Some provinces and territories in Canada have already adopted an opt-out strategy to prenatal HIV screeningFootnote 26.
Increasing knowledge and awareness
Increasing the availability of HIV-related knowledge translation material to improve awareness could be useful to highlight the benefits of testing. When patients are educated about the benefits of testing and are educated with respect to HIV (for instance, regarding the effectiveness of antiretroviral therapies and methods for reducing transmission risk), they are more likely to be testedFootnote 34. Adam et al. found that greater HIV knowledge was associated with better testing routines among MSMFootnote 37. Studies examining the predictors of HIV testing suggest that individuals are more likely to seek testing if they foresee positive outcomes (e.g., protecting family, peace of mind) as opposed to negative ones (e.g., stigma)Footnote 29Footnote 37. Studies examining facilitators or factors associated with recent HIV testing suggest that increasing patient and health care provider knowledge using HIV literature and HIV-specific training is a potential facilitatorFootnote 13Footnote 17Footnote 23. Health care providers found that patient interest and willingness, as well as knowledge of local consent and counselling regulations were facilitators to testingFootnote 13Footnote 23.
Not surprisingly, health care providers suggest improvement in HIV-specific training for providers, increased availability of HIV literature for providers and patients, patient education initiatives, and improvements in provider communication as possible facilitators of routine HIV testingFootnote 13Footnote 17Footnote 23. The Guide recommends “[streamlining] the provision of pre-test information using print, video, mobile and web-based resources”Footnote 1.
A summary of recent studies of facilitators of HIV testing is presented in Appendix 2.
Discussion
Our overview of the recent literature confirmed the ongoing importance of all the barriers that were identified in the HIV Screening and Testing Guide: lack of perceived risk, lack of comfort or knowledge, provider time constraints, and fear, stigma, and discrimination. Additional barriers identified in this review include fears regarding disclosure or a lack of confidentiality, lack of access, lack of compensation for providers, and the lack of human resources to carry out testing initiatives.
In terms of facilitators, while the Guide does recommend the normalization of HIV screening and testing, and touches upon the topic of increasing awareness (e.g., by emphasizing HIV as a chronic manageable condition), little is mentioned regarding opt-out testing as a potential facilitatorFootnote 1. Opt‑out testing was identified as a facilitator in this overview, as it addresses some key barriers. Although it is currently used in some parts of Canada as part of prenatal screening, it is unclear whether opt-out testing for the general population will result in significant improvements in identifying HIV‑positive individuals.
A strength of the current overview is that it provides a brief snapshot of what has been learned about barriers and facilitators of HIV screening and testing since the creation of the Guide in 2012. A limitation of this overview is that it only included studies from high-income countries. This may limit global generalizability of the results, but they remain relevant for Canada. Also, there was no systematic assessment of bias performed for the included studies. This overview, however, is intended to provide a snapshot of the evidence, as opposed to grading the quality of that evidence.
This study has identified a number of areas for future work. First, these findings could be used to inform future iterations of the Guide, and could be used by other organizations to inform programming. Second, while it is important to identify and be aware of important barriers, more research could be performed to review and evaluate interventions aimed at addressing these barriers (e.g., knowledge translation products, campaigns, etc.). Third, HIV testing strategies such as couples testing and self-testing were not identified as facilitators in the current review. Future research could consider the merits of these strategies. Finally, overall there was a lack of Canadian studies; thus, studies to confirm the relevance of the above-mentioned barriers and facilitators in the Canadian context would be useful.
Conclusion
Understanding the major barriers and facilitators to HIV testing is essential to increase the number of individuals being tested for HIV as it can inform effective strategies to decrease the 21% of those infected who are unaware of their HIV statusFootnote 2. Targeted interventions could address the barriers and capitalize on the facilitators.
Acknowledgements
The authors would like to acknowledge Jun Wu and Simon Foley from the Public Health Agency of Canada for their support in the development of this article.
Conflict of interest
None
Funding
The authors have no sources of external funding to declare.
Appendix 1: Summary of studies on barriers to HIV testing
Author (year) |
Country/ region |
Question(s)/ study objective |
Method | Population | Key findings/ barriers identified |
---|---|---|---|---|---|
Lorenc |
England |
What is the qualitative evidence related to views and attitudes of MSM concerning HIV testing? |
Systematic review |
Men who have sex with men (MSM) |
Barriers include:
|
Deblonde et al. (2010)Footnote 3 |
11 countries in Europe, the Middle East and Russia |
What are barriers to HIV testing? |
Systematic review |
Various |
For patients:
For providers:
|
CDC (2013)Footnote 22 |
United States |
Examine trends in testing among different groups—discusses barriers in “commentary” section. |
Review |
Several |
For patients:
For providers:
|
DeMarco et al. (2012)Footnote 28 |
United States |
Barriers to following CDC recommendation of routine HIV testing |
Review |
Various |
For patients:
For providers:
|
Wertheimer (2011)Footnote 26 |
Canada |
What are the barriers that women face when it comes to HIV testing/ screening? |
Review |
Women |
For patients:
For providers:
|
Yazdanpanah et al. (2010)Footnote 34 |
24 countries in Europe and Russia |
Barriers to earlier testing: Why do patients present late? How to overcome barriers? |
Review |
Several studies with variety of populations |
For patients:
For providers:
|
Deblonde et al. (2014)Footnote 4 |
Belgium, Estonia, Finland, Portugal |
What are reasons for HIV testing, or reasons for not having been tested prior to HIV diagnosis? |
Survey |
Recently diagnosed HIV-positive patients (72% male) |
Reasons for not testing:
|
Hallmark et al. (2014)Footnote 14 |
United States |
To what extent do you agree with a number of possible barriers using a five-point scale? |
Survey |
HIV testing coordinators, program directors, nurse managers, and/or lab directors, in various settings |
Highest rated/frequently selected:
|
Iqbal, DeSouza & Yudin (2014)Footnote 27 |
Canada |
Willingness to accept testing (yes/no) and attitudes towards HIV testing in labour. What are differences between those who accept and those who don’t? |
Survey |
HIV-negative expectant mothers presenting at hospital in labour |
Top reasons for not accepting:
|
Prestage, Brown & Keen (2012)Footnote 5 |
Australia |
What are reasons for delaying or avoiding HIV testing? |
Survey |
HIV-negative men |
Commonly selected barriers:
|
Arbelaez et al. (2012)Footnote 24 |
United States |
What are barriers to implementing routine HIV testing in emergency department? |
Survey |
Health care providers in emergency department |
Most frequently cited barriers:
|
Shirreffs et al. (2012)Footnote 12 |
United States |
Agree/disagree with commonly reported barriers? |
Survey |
Health care providers |
|
Berkenblit et al. (2012)Footnote 15 |
United States |
Do you encourage their trainees to perform routine HIV testing (yes/no)? If not, what are the reasons (select from several options)? |
Survey |
Clinical educators from the Society of General Internal Medicine |
Reasons for not encouraging routine testing:
|
Korthius et al. (2011)Footnote 23 |
United States |
Agree/disagree with commonly reported barriers? |
Survey |
Internal medicine specialists |
|
Mimiaga et al. (2011)Footnote 20 |
United States |
What are barriers to the implementation of routine HIV testing at the site? |
Survey |
Senior administrators, medical directors and health care providers from community health centres |
|
Glasman et al. (2010)Footnote 29 |
United States |
What factors influence individuals’ intentions to seek/accept HIV testing? |
Survey |
Heterosexual men of Mexican decent |
Less likely to seek testing if:
|
Bogart et al. (2010)Footnote 18 |
United States |
What are barriers to providing rapid HIV testing? |
Survey |
Laboratory and department staff from hospitals |
For labs:
For hospital departments:
For clinics/community-based organizations:
|
White et al. (2014)Footnote 9 |
United States |
What are perceptions of barriers and facilitators to implementing routine HIV testing according to primary care physicians? |
Interview |
Primary care physicians |
For patients:
For providers:
|
Schwartz, Block & Schafer (2014)Footnote 6 |
United States |
What are factors that led to, or are associated with, late diagnosis? |
Interview |
Individuals who received a late diagnosis of HIV (defined as having developed AIDS within 12 months of HIV diagnosis) |
Recurrent themes in interviews:
|
Brennan et al. (2013)Footnote 10 |
United States |
What are barriers and facilitators to adoption of universal HIV screening in a low-prevalence setting? |
Interview |
Internal medicine residents |
Physicians perceived discussions about HIV testing as challenging due to:
|
Sison et al. (2013)Footnote 11 |
United States |
What are physicians’ attitudes and practices regarding HIV testing and linkage to care? |
Interview |
Primary care physicians and infectious disease specialists |
For patients:
For providers:
|
Hyden, Allegrante & Cohall (2013)Footnote 30 |
United States |
What potential barriers might adolescents face when seeking HIV testing? |
Interview |
HIV testing site representatives |
|
Hudson, Heilemann & Rodriguez (2012)Footnote 17 |
United States |
What are primary care providers’ perspectives on, and experiences of, facilitators and barriers to offering voluntary HIV counselling and testing to all patients aged 13 to 64 as part of annual screening? |
Interview |
Primary care providers (defined as family practice, internal medicine or pediatrics) |
|
Mills et al. (2011)Footnote 8 |
United States |
What were barriers to an HIV-positive individual’s initial test? |
Interview |
HIV-positive individuals |
Commonly selected:
|
Johnson et al. (2011)Footnote 19 |
United States |
What are barriers to testing for health care providers? |
Interview |
Senior staff at community health centres |
|
Schwarcz et al. (2011)Footnote 7 |
United States |
What are the factors that led to late testing/diagnosis of HIV? |
Interview |
Individuals who developed AIDS within 12 months of HIV diagnosis (88.4% male) |
|
Simmons et al. (2011)Footnote 13 |
United States |
What are barriers and facilitators of routine HIV testing? |
Interview |
Health care providers |
|
Myers, Koester & Dufour (2011)Footnote 21 |
United States |
What are barriers to implementing and/or expanding HIV testing? What are strategies to overcome these barriers? |
Interview |
Program funding and managing administrators, and medical directors/ physicians providing care in clinics |
For providers:
|
Trepka et al. (2014)Footnote 31 |
United States |
What are factors associated with late diagnosis in rural and urban dwelling individuals? |
Chart review |
Individuals who received a late HIV diagnosis (developed AIDS within three months of diagnosis) |
|
Appendix 2: Summary of studies on facilitators to HIV testing
Author (year) | Country | Question(s)/ study objective |
Method | Population | Key findings/ facilitators identified |
---|---|---|---|---|---|
Lorenc et al. (2011)Footnote 25 |
England |
What is the qualitative evidence related to views and attitudes of MSM concerning HIV testing? |
Systematic review |
Men who have Sex with Men (MSM) |
Motives for testing include:
|
Yazdanpanah et al. (2010)Footnote 34 |
24 countries in Europe and Russia |
Barriers to earlier testing: Why do patients present late? How to overcome barriers? |
Review |
Several studies with variety of populations |
For patients:
|
Adam et al. (2014)Footnote 37 |
Australia |
What social-cognitive factors are associated with stronger HIV testing routines? |
Survey |
HIV-negative MSM |
Correlates of HIV testing in multivariate analysis:
|
Knussen, Flowers & McDaid (2014)Footnote 36 |
Scotland |
Which factors differ between individuals who have tested in the past year, who have tested more than one year ago, and who have never tested for HIV? |
Survey |
Convenience sample of Scottish MSM |
Individuals who reported testing in the past year had:
And were more likely to have:
|
Deblonde et al. (2014)Footnote 4 |
Belgium, Estonia, Finland, Portugal |
What are reasons for HIV testing, or reasons for not having been tested prior to HIV diagnosis? |
Survey |
Recently diagnosed HIV-positive patients |
Reasons prompting a test:
|
Sawlesh-warkar et al. (2011)Footnote 32 |
Australia |
What factors are associated with HIV testing by general practitioners? |
Survey |
General practitioners |
Predictors of HIV testing included:
|
Korthius et al. (2011)Footnote 23 |
United States |
Agree/disagree with commonly reported barriers? |
Survey |
Internal medicine specialists |
Commonly selected facilitators:
|
Haines et al. (2011)Footnote 33 |
United States |
What are adolescents’ attitudes and preferences towards emergency department-based HIV testing, future plans for testing, and counselling? |
Survey |
Convenience sample of adolescents (aged 14 to 21) receiving opt-in rapid HIV testing in an emergency department |
|
Glasman et al. (2010)Footnote 29 |
United States |
What factors influence individuals’ intentions to seek and/or accept free HIV testing? |
Survey |
Heterosexual men of Mexican decent |
More likely to seek/accept testing if:
|
Stefan et al. (2010)Footnote 16 |
United States |
What are the correlates of self-reported HIV testing? |
Survey |
Adult patients in academic internal medicine clinics |
Univariate correlates of HIV testing:
Multivariate regression model predictors of HIV testing:
|
Brennan et al. (2013)Footnote 10 |
United States |
What are barriers and facilitators to adoption of universal HIV screening in a low-prevalence setting? |
Interview |
Internal medicine residents |
Majority of patients were especially receptive to HIV screening when normalized and when an expert authority was referenced (e.g., CDC) |
Sison et al. (2013)Footnote 11 |
United States |
What are physicians’ attitudes and practices regarding HIV testing and linkage to care? |
Interview |
Primary care physicians and infectious disease specialists |
For providers:
|
Hudson, Heilemann & Rodriguez (2012)Footnote 17 |
United States |
What are primary care providers’ perspectives on, and experiences of, facilitators and barriers to offering voluntary HIV counselling and testing to all patients aged 13 to as part of annual screening? |
Interview |
Primary care providers (defined as family practice, internal medicine, or pediatrics) |
|
Simmons et al. (2011)Footnote 13 |
United States |
What are barriers and facilitators of routine HIV testing? |
Interview |
Health care providers |
|
Myers, Koester & Dufour (2011)Footnote 21 |
United States |
What are barriers to implementing and/or expanding HIV testing? What are strategies to overcoming these barriers? |
Interview |
Program funding and managing administrators, and medical directors/ physicians providing care in clinics |
|
Page details
- Date modified: